How many clinical trials are there for glp1 Agonist?

PlainTrial tracks 1 US clinical trials for glp1 Agonist, of which 1 are currently recruiting.

Which interventions appear most often on glp1 Agonist trial records?

ellacor is the most-linked intervention name on glp1 Agonist records (1 trial links). Names are sponsor-reported on ClinicalTrials.gov.

How do I find a recruiting trial for glp1 Agonist?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

glp1 Agonist clinical trials

Compiled by PlainTrial · August 8, 2026

1 of 1 indexed glp1 Agonist trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

glp1 Agonist: 1 US clinical trial tracked, 1 recruiting.

glp1 Agonist is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Cytrellis Biosystems, running 1 of these trials.

Enrollment posture brief

Registry condition glp1-agonist

Volume-matched condition peers

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Open-enrollment share among volume-matched conditions near glp1 Agonist

glp1 Agonist lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for glp1 Agonist on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

glp1 Agonist is recruiting above its size-band peers.

1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Open and recent trials

1 total, page 1 of 1

RECRUITING 10 participants

Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists

Cytrellis Biosystems

NCT07224880

Phase Distribution

Phase data not available

Top Sponsors

Cytrellis Biosystems 1 trials

Named interventions

Most-linked intervention names on glp1 Agonist records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

ellacor Device

1 trials

US sites by state

Facility locations filed on glp1 Agonist trials. A trial with sites in several states counts in each.

California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Read our methodology - how this data is sourced, computed, and verified.

What to do with this glp1 Agonist page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

1 glp1 Agonist trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
Cytrellis Biosystems sponsors the most glp1 Agonist trials on record, review their full trial history before evaluating a specific study. See Cytrellis Biosystems's trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This glp1 Agonist condition card totals 1 registered trials; most-linked intervention ellacor; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.